Johnson & Johnson

World Rank (Jan-05-2024)

21

Market Cap (Jan-05-2024)

387.499 Billion USD

World Rank (Jul-30-2023)

15

Market Cap (Jul-30-2023)

453.430 Billion USD

World Rank (Jan-07-2022)

14

Market Cap (Jan-07-2022)

457.940 Billion USD

World Rank (Jan-01-2021)

14

Market Cap (Jan-01-2021)

414.310 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 12

Headquarters Country

USA

Nasdaq / NYSE Code

JNJ

Market Cap (Mar-08-2026)

579.34

CEO

Joaquin Duato

Chairman

William C. Weldon

Founders

James Wood Johnson

Robert Wood Johnson I

Edward Mead Johnson

Employee Count

155,800

Employee Count as of Date

As on Jan-2023

Headquarters City/State

New Jersey

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

85,159 Million USD

Annual Operating Income in USD

22,009 Million USD

Annual Net Income in USD

35,153 Million USD

Annual Results for Period Ending

Dec-2023 ending year

Total Assets in USD

167,558 Million USD

Total Liabilities in USD

98,784 Million USD

Total Equity in USD

68,774 Million USD

Balance Sheet for Period Ending

Dec-2023 ending year

Business Sector

Healthcare

Medical Equipment / Instruments

Pharmaceutical

FMCG

Biotechnology

Company Website

Johnson & Johnson - Top Consumer Goods, Pharmaceuticals, Medical Devices Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Johnson & Johnson manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2023, Johnson & Johnson has 155,800 employees across 60 countries. Headquarters is in USA.

As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

Facts About Company

Johnson & Johnson annual revenue generated for period ending Dec-2023 was 85.15 Billion USD and annual net income was 35.15 Billion USD
Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD and annual net income was 17.94 Billion USD.
Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD and annual net income was 20.87 Billion USD.

Johnson & Johnson annual sales by segment wise for period ending in Dec-2022:

Consumer Health segment annual sales in 2022 was 14,953 Million USD.
Pharmaceutical segment annual sales in 2022 was 52,563 Million USD.
MedTech segment annual sales in 2022 was 27,427 Million USD.

Annual Results Summary

Johnson & Johnson - Annual Results Summary - in Billion USD:

ANNUAL RESULTS	Total Revenue	Operating Income	Net Income
Dec-2024	88.82	22.14	14.06
Dec-2023	85.15	22.01	35.15
Dec-2022	94.94	23.70	17.94
Dec-2021	93.77	24.54	20.87
Dec-2020	82.58	19.73	14.71
Dec-2019	82.05	20.08	15.12
Dec-2018	81.58	20.05	15.29
Dec-2017	76.45	18.71	1.30
Dec-2016	71.89		15.40
Dec-2015	70.07		15.41

Balance Sheet Summary

Johnson and Johnson - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2024	180,104	108,614	71,490
Dec-2023	167,558	98,784	68,774
Dec-2022	187,378	110,574	76,804
Dec-2021	182,018	107,995	74,023
Dec-2020	174,894	111,616	63,278
Dec-2019	157,728	98,257	59,471
Dec-2018	152,954	93,202	59,752
Dec-2017	157,303	97,143	60,160
Jan-2017	141,208	70,790	70,418

Founded Year

1886

Institutional Investors

Top 30 Institutional Investors in JOHNSON & JOHNSON as on MAR-31-2023

RANK	Institutional Investors	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	3/31/2023	246,930,357	103,736	0.04%	$42,763,399
2	BLACKROCK INC.	3/31/2023	201,491,567	2,688,798	1.35%	$34,894,310
3	STATE STREET CORP	3/31/2023	140,265,123	-1,819,255	-1.28%	$24,291,114
4	GEODE CAPITAL MANAGEMENT, LLC	3/31/2023	48,707,500	748,917	1.56%	$8,435,165
5	MORGAN STANLEY	3/31/2023	40,003,520	-2,221,001	-5.26%	$6,927,810
6	NORTHERN TRUST CORP	3/31/2023	33,474,647	-282,321	-0.84%	$5,797,139
7	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	3/31/2023	31,675,492	0	0%	$5,485,562
8	BANK OF AMERICA CORP /DE/	3/31/2023	30,352,766	-758,382	-2.44%	$5,256,492
9	PRICE T ROWE ASSOCIATES INC /MD/	3/31/2023	26,833,801	-2,443,973	-8.35%	$4,647,078
10	NORGES BANK	12/31/2022	26,093,398	1,609,376	6.57%	$4,518,855
11	JPMORGAN CHASE & CO	3/31/2023	25,723,516	-5,938,961	-18.76%	$4,454,799
12	WELLINGTON MANAGEMENT GROUP LLP	3/31/2023	25,386,775	-1,474,344	-5.49%	$4,396,482
13	BANK OF NEW YORK MELLON CORP	6/30/2023	23,470,152	-676,685	-2.80%	$4,064,561
14	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	3/31/2023	21,097,191	-48,566	-0.23%	$3,653,612
15	WELLS FARGO & COMPANY/MN	3/31/2023	20,184,884	136,017	0.68%	$3,495,618
16	LEGAL & GENERAL GROUP PLC	3/31/2023	18,735,910	325,520	1.77%	$3,244,685
17	FMR LLC	3/31/2023	17,747,706	-1,344,454	-7.04%	$3,073,548
18	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	3/31/2023	17,146,319	59,748	0.35%	$2,969,400
19	CAPITAL INTERNATIONAL INVESTORS	3/31/2023	17,101,685	-467,969	-2.66%	$2,961,670
20	DEUTSCHE BANK AG\	3/31/2023	15,251,191	13,025	0.09%	$2,641,201
21	AMERIPRISE FINANCIAL INC	3/31/2023	14,925,194	-2,544,534	-14.57%	$2,584,745
22	INVESCO LTD.	3/31/2023	13,901,658	1,282,831	10.17%	$2,407,489
23	ROYAL BANK OF CANADA	3/31/2023	13,371,002	-1,109,276	-7.66%	$2,315,590
24	FRANKLIN RESOURCES INC	3/31/2023	12,250,638	-89,988	-0.73%	$2,121,565
25	ROBERT WOOD JOHNSON FOUNDATION	3/31/2023	12,145,550	0	0%	$2,103,366
26	GOLDMAN SACHS GROUP INC	3/31/2023	11,506,763	-1,061,987	-8.45%	$1,992,741
27	BARCLAYS PLC	6/30/2023	11,287,765	4,059,112	56.15%	$1,954,815
28	UBS ASSET MANAGEMENT AMERICAS INC	3/31/2023	11,209,368	165,097	1.50%	$1,941,238
29	NUVEEN ASSET MANAGEMENT, LLC	3/31/2023	10,888,307	-31,613	-0.29%	$1,885,637
30	UBS GROUP AG	3/31/2023	10,806,220	-1,608,156	-12.95%	$1,871,421